Cambridge Healthtech Institute’s 14th Annual

Portfolio Management

Aligning Portfolio and Productivity with Corporate Strategy to Drive Innovation and Value

October 17-18, 2019


In an environment of declining revenues and uncertain commercial success, biopharma, device and R&D companies need to continuously evaluate their portfolios. Manufacturers must make tough decisions about which products and projects to pursue to optimize long-term revenue and reduce overall risk. Cambridge Healthtech Institute’s and the BioPharma Strategy Series’ 14th Annual Portfolio Management: Aligning Portfolio and Productivity with Corporate Strategy to Drive Innovation attracts over 100 senior R&D executives from the pharma, biotech, device, IT, public and governmental communities who share best practices in project and portfolio management, R&D innovation, decision analysis, change management, forecasting, and the improvement of operational models. Effective portfolio management requires the alignment of portfolio and productivity with corporate strategy, supporting agile development and adaptation of data into planning.

JOINT KEYNOTE SESSION: BUILDING A DATA-DRIVEN CULTURE FOR OPTIMIZED RESOURCE AND PORTFOLIO DECISION MAKING

How to Develop an After-Action Review Culture – A Guide to Incremental BUT Impactful Change Management

Michael Myers, PhD, Senior Director, LRL Due Diligence, Eli Lilly & Co.

Analytics and Culture: Lessons Learned and Comparisons between Pharma/Biotech, Oil & Gas, and Government

Timothy Nieman, Senior Manager, Portfolio Analysis, Portfolio Management Office, BioMarin Pharmaceutical

CORPORATE STRATEGY AND GOVERNANCE

Linking Corporate Strategic Portfolio to Projects through Governance

Matthew Kokkonen, Director, Portfolio Management and Governance, CSL Behring

Analyzing Governance Decision Making and the Impact of Team Preparedness

Christine Antis, Senior Director, Portfolio Governance and Head of Portfolio Decision Sciences, Portfolio Management, GlaxoSmithKline

IMPLEMENTING AND IMPROVING PORTFOLIO MANAGEMENT PROCESSES

Transformation Journey – Schedule Development & Execution

Gary Shives, Director, Project Management Office, Eli Lilly

Pragmatic Approach to Implementing Portfolio Management and Optimization

Crissy Tevis, Director, TOPS Portfolio Management, Technical Operations, BioMarin Pharmaceuticals

An Agile Approach to Portfolio Planning

Candy Liang, Director, Strategic Planning, Akebia Therapeutics

TOOLS AND MODELS FOR EFFECTIVE PORTFOLIO MANAGEMENT

Building a Financial Model for Assets

Delfi Krishna, PhD, Director of Operations, Planning and Strategy, Cell and Gene Therapy Platform, GS

Validated Probability Assessments – Insights from Lilly’s 20 Years of Experience

Charles Persinger, Senior Research Advisor, Portfolio Strategy & Decision Sciences, Eli Lilly and Company

PANEL DISCUSSION: Simplifying Portfolio and Resource Management Processes in the Age of Analytics

Moderator: Daniel Patrick, Senior Director, Global Project Management and Leadership, Daiichi Sankyo

Panelists: Mark Lane, Executive Director of Drug Development, PRA Health Sciences
Raghu Sethuram, Senior Director, Global Portfolio Management, Pfizer Consumer Healthcare


 

For more details on the conference, please contact:

Kaitlin Searfoss Kelleher

Conference Producer

Cambridge Healthtech Institute

Phone: (+1) 781-972-5498

Email: kkelleher@healthtech.com

 

For partnering and sponsorship information, please contact:
Katelin Fitzgerald

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5458

Email: kfitzgerald@healthtech.com


Register Today!

For questions about this year's event, please contact:

Kaitlin Searfoss Kelleher
Conference Producer
Cambridge Healthtech Institute
T: (+1) 781-972-5498
E: kkelleher@healthtech.com